{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:22:00Z","timestamp":1761153720412},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00431-012-1814-5","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T04:05:20Z","timestamp":1347336320000},"page":"1579-1588","source":"Crossref","is-referenced-by-count":29,"title":["Educational Paper: Progression in chronic kidney disease and prevention strategies"],"prefix":"10.1007","volume":"171","author":[{"given":"Betti","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000075925","volume":"24","author":"CK Abrass","year":"2004","unstructured":"Abrass CK (2004) Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 24:46\u201353","journal-title":"Am J Nephrol"},{"key":"1814_CR2","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qui P, Williams L, Batlle W (2005) Antiproteinuric effect of oral paracalcitol in chronic kidney disease. Kidney Int 68:2823\u20132828","journal-title":"Kidney Int"},{"key":"1814_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00467-003-1268-0","volume":"19","author":"G Ardissino","year":"2004","unstructured":"Ardissino G, Testa S, Dacco V, Vigano S, Taioli E, Claris-Appiani A, Procaccio M, Avolio L, Ciofani A, Dello Strologo L, Montini G (2004) Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Pediatr Nephrol 19:172\u2013177","journal-title":"Pediatr Nephrol"},{"key":"1814_CR4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/ndt\/gfm237","volume":"22","author":"G Ardissino","year":"2007","unstructured":"Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, la Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM, on behalf of the ItalKid Project (2007) No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy - report from the ItalKid Project database. Nephrol Dial Transplant 22:2525\u20132530","journal-title":"Nephrol Dial Transplant"},{"key":"1814_CR5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.ki.5002483","volume":"72","author":"Z Aydin","year":"2007","unstructured":"Aydin Z, Duijs J, Bajerna IM, van Zonneveld AJ, Rabelink TJ (2007) Erythropoietin, progenitors, and repair. Kidney Int 72:516\u2013520","journal-title":"Kidney Int"},{"key":"1814_CR6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","volume":"36","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Williams M, Dworkin L, Elliot WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646\u2013661","journal-title":"Am J Kidney Dis"},{"key":"1814_CR7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486\u2013492","journal-title":"Nat Clin Pract Nephrol"},{"key":"1814_CR8","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","volume":"366","author":"JP Casas","year":"2005","unstructured":"Casas JP, Weiliang C, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366:2026\u20132033","journal-title":"Lancet"},{"key":"1814_CR9","first-page":"CD006863","volume":"17","author":"S Chaturvedi","year":"2007","unstructured":"Chaturvedi S, Jones C (2007) Protein restriction for children with chronic renal failure. Cochrane Database Syst Rev 17:CD006863","journal-title":"Cochrane Database Syst Rev"},{"key":"1814_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167\u2013174","journal-title":"Ann Intern Med"},{"key":"1814_CR11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Barkis GL, Black DL, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560\u20132571","journal-title":"JAMA"},{"key":"1814_CR12","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","volume":"22","author":"MH Borst De","year":"2011","unstructured":"De Borst MH, Vervloet MG, ter Wee PM, Navis G (2011) Cross talk between the renin\u2013angiotensin\u2013aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 22:1603\u20131609","journal-title":"J Am Soc Nephrol"},{"key":"1814_CR13","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I Brito-Ashurst de","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20:2075\u20132084","journal-title":"J Am Soc Nephrol"},{"key":"1814_CR14","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.HYP.0000161880.59963.da","volume":"45","author":"TW Doulton","year":"2005","unstructured":"Doulton TW, He FJ, MacGregor FA (2005) Systemic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 45:880\u2013886","journal-title":"Hypertension"},{"key":"1814_CR15","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Dr\u00fceke","year":"2006","unstructured":"Dr\u00fceke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, Investigators CREATE (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071\u20132084","journal-title":"N Engl J Med"},{"key":"1814_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(03)00279-8","volume":"143","author":"D Ellis","year":"2003","unstructured":"Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE (2003) Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr 143:89\u201397","journal-title":"J Pediatr"},{"key":"1814_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.ajkd.2004.08.040","volume":"45","author":"M Epstein","year":"2005","unstructured":"Epstein M, Campese VM (2005) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. Am J Kidney Dis 45:2\u201314","journal-title":"Am J Kidney Dis"},{"key":"1814_CR18","unstructured":"European Medicines Agency (2012) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2012\/02\/WC500122919.pdf"},{"key":"1814_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-1241.1999.tb11793.x","volume":"53","author":"W Fassbinder","year":"1999","unstructured":"Fassbinder W, Quarder O, Waltz A (1999) Treatment with carvedilol is associated with a significant reduction in microalbuminuria: a multicenter randomized study. Int J Clin Pract 53:519\u2013522","journal-title":"Int J Clin Pract"},{"key":"1814_CR20","doi-asserted-by":"crossref","unstructured":"Fouque D, Laville M (2009) Low-protein diets for chronic kidney disease in non diabetic adults. Cochrane database of systematic reviews, Issue 3, Art.No. CD001892. doi: 10.1002\/14651858.CD001892.pub3","DOI":"10.1002\/14651858.CD001892.pub3"},{"key":"1814_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1523-1755.2004.00797.x","volume":"66","author":"C Gouva","year":"2004","unstructured":"Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC (2004) Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 66:753\u2013760","journal-title":"Kidney Int"},{"key":"1814_CR22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ, Hoppe B, Beck B, T\u00f6nshoff B, H\u00f6cker B, Wygoda S, Erich JHH, Pape L, Konrad M, Rascher W, D\u00f6tsch J, M\u00fcller-Wiefel DE, Hoyer P, and Study Group Members of the Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN), Knebelmann B, Pirson Y, Grunfeld J-P, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, M\u00fcller GA, Weber M (2012) Early angiotensin converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494\u2013501","journal-title":"Kidney Int"},{"key":"1814_CR23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.309.6958.833","volume":"309","author":"T Hannedouche","year":"1994","unstructured":"Hannedouche T, Landais P, Goldfarb B, el Esper N, Fournier A, Godin M, Durand D, Chanard J, Mihnin F, Suo JM (1994) Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 309:833\u2013837","journal-title":"BMJ"},{"key":"1814_CR24","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, Ikemiya Y, Iseki C, Takishita S (2003) Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63:1468\u20131474","journal-title":"Kidney Int"},{"key":"1814_CR25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0272-6386(04)01080-7","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Kinjo K, Iseki C, Takishita S (2004) Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 44:806\u2013814","journal-title":"Am J Kidney Dis"},{"key":"1814_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","volume":"135","author":"TH Jafar","year":"2001","unstructured":"Jafar TH, Schmid CH, Landa M, Giatras J, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, DeJong P, DeZeeuw D, Lau J, Levey AS, for the ACE Inhibition in Progressive Renal Disease Study Group (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135:73\u201387","journal-title":"Ann Intern Med"},{"key":"1814_CR27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD study group (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-meta-analysis. Ann Intern Med 139:244\u2013252","journal-title":"Ann Intern Med"},{"key":"1814_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000112413","volume":"28","author":"I Karamouzis","year":"2008","unstructured":"Karamouzis I, Sarafidis PA, Karamouzis M, Illiadis S, Haidich A-M, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM (2008) Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol 28:397\u2013404","journal-title":"Am J Nephrol"},{"key":"1814_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"MJ Klag","year":"1996","unstructured":"Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13\u201318","journal-title":"N Engl J Med"},{"key":"1814_CR30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S, Levy AD, Beck GJ (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877\u2013884","journal-title":"N Engl J Med"},{"key":"1814_CR31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1053\/j.ajkd.2006.08.016","volume":"48","author":"AS Levey","year":"2006","unstructured":"Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins AJ, Kopple JD (2006) Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 48:876\u2013888","journal-title":"Am J Kidney Dis"},{"key":"1814_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P (2002) 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin\u2013angiotensin system. J Clin Invest 110:229\u2013238","journal-title":"J Clin Invest"},{"key":"1814_CR33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00467-003-1329-4","volume":"19","author":"M Litwin","year":"2004","unstructured":"Litwin M (2004) Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 19:178\u2013186","journal-title":"Pediatr Nephrol"},{"key":"1814_CR34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/oxfordjournals.ndt.a027312","volume":"11","author":"F Locatelli","year":"1996","unstructured":"Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A (1996) Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italien Cooperative Study Group. Nephrol Dial Transplant 11:461\u2013467","journal-title":"Nephrol Dial Transplant"},{"key":"1814_CR35","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","volume":"27","author":"E Lurbe","year":"2009","unstructured":"Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, W\u00fchl E, Zanchetti A (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719\u20131742","journal-title":"J Hypertens"},{"key":"1814_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ajkd.2006.04.077","volume":"48","author":"M MacKinnon","year":"2006","unstructured":"MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48:8\u201320","journal-title":"Am J Kidney Dis"},{"key":"1814_CR37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of angiotensin-converting-enzme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939\u2013945","journal-title":"N Engl J Med"},{"key":"1814_CR38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0140-6736(90)93090-C","volume":"335","author":"H Mulec","year":"1990","unstructured":"Mulec H, Johnson SA, Bjorck S (1990) Relation between serum cholesterol and diabetic nephropathy. Lancet 335:1537\u20131538","journal-title":"Lancet"},{"key":"1814_CR39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2000","unstructured":"Muntner P, Coresh J, Clinton Smith J, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58:293\u2013301","journal-title":"Kidney Int"},{"key":"1814_CR40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555\u2013576","journal-title":"Pediatrics"},{"key":"1814_CR41","unstructured":"National Kidney Foundation (2003) K\/DOQI Clinical practice guidelines for managing dyslipidemias in patients with kidney disease. Am J Kidney Dis 41:S1\u2013S91 (Suppl 3)"},{"key":"1814_CR42","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2004) K\/DOQI Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:S1\u2013S290 (Suppl 1)","DOI":"10.1053\/j.ajkd.2004.03.003"},{"key":"1814_CR43","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2005) K\/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:S12\u2013S122 (Suppl 1)","DOI":"10.1053\/j.ajkd.2005.07.028"},{"key":"1814_CR44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","volume":"14","author":"H Ogata","year":"2003","unstructured":"Ogata H, Ritz E, Odoni G, Amann K, Orth SR (2003) Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 14:959\u2013967","journal-title":"J Am Soc Nephrol"},{"key":"1814_CR45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ki.2011.105","volume":"80","author":"J Oh","year":"2011","unstructured":"Oh J, Beckmann J, Bloch J, Hettgen V, Mueller J, Li L, Hoemme M, Gross ML, Penzel R, Mundel P, Schaefer F, Schmitt CP (2011) Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int 80:483\u2013492","journal-title":"Kidney Int"},{"key":"1814_CR46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"1814_CR47","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleigth P, Anderson C (2008) Renal outcomes with telmisartan, ramipril, or both, in patients at high vascular risk (The ONTARGET Study): a multicenter, randomized, double-blind, controlled trial. N Engl J Med 358:1547\u20131559","journal-title":"N Engl J Med"},{"key":"1814_CR48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(07)61124-6","volume":"370","author":"S Oparil","year":"2007","unstructured":"Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A (2007) Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomized, double-blind trial. Lancet 370:221\u2013229","journal-title":"Lancet"},{"key":"1814_CR49","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","volume":"1","author":"HH Parving","year":"1983","unstructured":"Parving HH, Andersen AR, Smidt UM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175\u20131179","journal-title":"Lancet"},{"key":"1814_CR50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bmj.297.6656.1086","volume":"297","author":"HH Parving","year":"1988","unstructured":"Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. BMJ 297:1086\u20131091","journal-title":"BMJ"},{"key":"1814_CR51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","volume":"123","author":"JC Peterson","year":"1995","unstructured":"Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter LJ (1995) Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study. Ann Intern Med 123:754\u2013762","journal-title":"Ann Intern Med"},{"key":"1814_CR52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.ki.5002391","volume":"72","author":"M Rao","year":"2007","unstructured":"Rao M, Wong C, Kanetsky P, Girndt M, Stenvinkel P, Reilly M, Raj DSC (2007) Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int 72:549\u2013556","journal-title":"Kidney Int"},{"key":"1814_CR53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","volume":"354","author":"P Ruggenenti","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G, Garini G, Zocalli C, Salvadori M, Scolari F, Schena FP, Remuzzi G (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359\u2013364","journal-title":"Lancet"},{"key":"1814_CR54","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","volume":"63","author":"P Ruggenenti","year":"2003","unstructured":"Ruggenenti P, Perna A, Remuzzi G (2003) Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 63:2254\u20132261","journal-title":"Kidney Int"},{"key":"1814_CR55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00008480-200204000-00009","volume":"14","author":"MJ Saland","year":"2002","unstructured":"Saland MJ, Ginsberg H, Fisher EA (2002) Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Curr Opin Pediatr 14:197\u2013204","journal-title":"Curr Opin Pediatr"},{"key":"1814_CR56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-59259-797-0_21","volume-title":"Pediatric hypertension","author":"F Schaefer","year":"2004","unstructured":"Schaefer F, Mehls O (2004) Hypertension in chronic kidney disease. In: Portman RJ, Sorof JM, Ingelfinger JR (eds) Pediatric hypertension. Humana Press, Totowa, pp 371\u2013387"},{"key":"1814_CR57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","volume":"61","author":"RW Schrier","year":"2002","unstructured":"Schrier RW, Estacio RO, Esler A, Mehler P (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 61:1086\u20131097","journal-title":"Kidney Int"},{"key":"1814_CR58","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.ASN.0000135059.67385.5D","volume":"15","author":"EJ Sharples","year":"2004","unstructured":"Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Shaeff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115\u20132124","journal-title":"J Am Soc Nephrol"},{"key":"1814_CR59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","volume":"47","author":"YP Siu","year":"2006","unstructured":"Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51\u201359","journal-title":"Am J Kidney Dis"},{"key":"1814_CR60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2006.01.015","volume":"47","author":"GF Strippoli","year":"2006","unstructured":"Strippoli GF, Palmer S, Tong A, Elder G, Messa P, Craig JC (2006) Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 47:715\u2013726","journal-title":"Am J Kidney Dis"},{"key":"1814_CR61","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1442-200x.2004.01955.x","volume":"46","author":"H Tanaka","year":"2004","unstructured":"Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S (2004) Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int 46:576\u2013579","journal-title":"Pediatr Int"},{"key":"1814_CR62","first-page":"168A","volume":"11","author":"M Tarver-Carr","year":"2000","unstructured":"Tarver-Carr M, Brancati F, Eberhardt M, Powe N (2000) Proteinuria and the risk of chronic kidney disease (CKD) in the United States. J Am Soc Nephrol 11:168A","journal-title":"J Am Soc Nephrol"},{"key":"1814_CR63","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","author":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","year":"1997","unstructured":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephroptahy. Lancet 349:1857\u20131863","journal-title":"Lancet"},{"key":"1814_CR64","doi-asserted-by":"crossref","unstructured":"The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 25:1105\u20131187","DOI":"10.1097\/HJH.0b013e3281fc975a"},{"key":"1814_CR65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00467-004-1451-y","volume":"19","author":"M Dyck Van","year":"2004","unstructured":"Van Dyck M, Proesmans W (2004) Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr Nephrol 19:688\u2013690","journal-title":"Pediatr Nephrol"},{"key":"1814_CR66","first-page":"S58","volume":"63","author":"GG Essen van","year":"1997","unstructured":"van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D (1997) Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline? Kidney Int Suppl 63:S58\u2013S62","journal-title":"Kidney Int Suppl"},{"key":"1814_CR67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, M\u00e4rz W, Olschewski M, Mann JF, Ruf G, Ritz E, German Study Group for Growth Hormone Treatment in Chronic Renal Failure (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"},{"key":"1814_CR68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(03)00461-2","volume":"92","author":"WB White","year":"2003","unstructured":"White WB, Carr AA, Krause S, Jordan R, Roniker B, Oigman W (2003) Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. [Abstract]. Am J Cardiol 92:38\u201342","journal-title":"Am J Cardiol"},{"key":"1814_CR69","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(96)09260-4","volume":"349","author":"AM Wingen","year":"1997","unstructured":"Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349:1117\u20131123","journal-title":"Lancet"},{"key":"1814_CR70","doi-asserted-by":"crossref","unstructured":"Wolf M (2012) Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int, May 23 [Epub ahead of print]","DOI":"10.1038\/ki.2012.176"},{"key":"1814_CR71","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00467-008-0816-z","volume":"23","author":"C Wong","year":"2008","unstructured":"Wong C, Kanetsky P, Raj D (2008) Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol 23:1037\u20131051","journal-title":"Pediatr Nephrol"},{"key":"1814_CR72","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright Jr","year":"2003","unstructured":"Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG (2003) African American study of kidney disease and hypertension: effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421\u20132431","journal-title":"JAMA"},{"key":"1814_CR73","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"W\u00fchl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen A-M, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, M\u00f6ller K, Wigger M, Peruzzi L, Mehls O, Schaefer F (2009) Strict blood pressure control and renal failure progression in children. The ESCAPE Trial Group. N Engl J Med 361:1639\u20131650","journal-title":"N Engl J Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-012-1814-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1814-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T17:41:49Z","timestamp":1687714909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-012-1814-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s00431-012-1814-5","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}